Shubhi Pandey
Cardiovascular Disease · Farmington, CTNPI 1245716034
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (39.2%), food and beverage and grants — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Abbott at 41.0% of the total. 2025 is the largest year on record at $13,159, more than ten times the $331 reported in 2019. Among cardiovascular disease clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 229 payments — averaging $127.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$12K
- Medtronic$7K
- Medical Device Business Services, Inc.$4K
- Biotronik Inc.$2K
- Boston Scientific$2K
- Biosense Webster, Inc.$833
- plus $2K from 22 others
What the payments were for
- Grants$8,12528%
- Travel & lodging$11,44439%
- Food & beverage$8,87430%
- Education$7683%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 58 | $11,980 |
| Medtronic | 38 | $6,728 |
| Medical Device Business Services, Inc. | 26 | $4,151 |
| Biotronik Inc. | 14 | $1,896 |
| Boston Scientific | 4 | $1,640 |
| Biosense Webster, Inc. | 12 | $833 |
| AstraZeneca(2 entities) | 24 | $556 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $244 |
| Johnson & Johnson | 5 | $169 |
| Boehringer Ingelheim | 6 | $168 |
| AbbVie(2 entities) | 3 | $118 |
| Pfizer | 7 | $109 |
| Gilead | 5 | $109 |
| Philips North America LLC | 1 | $98 |
| Biogen | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Bayer | 2 | $40 |
| Jazz Pharmaceuticals Inc. | 2 | $40 |
| Shire North American Group Inc | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Viiv Healthcare Company | 1 | $21 |
| Incyte Corporation | 1 | $19 |
| Novartis | 1 | $18 |
| Lantheus Medical Imaging, Inc. | 1 | $17 |
| Merck | 1 | $12 |
| GSK | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ASSURITY$2,987
- TACTICATH$2,813
- Carto 3$2,599
- GENERAL - THERAPIES$1,640
- Micra$1,115
- GALLANT$913
- ENSITE PRECISION$903
- CARDIOMEMS$826
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$738
- Solia$689
- AMVIA EDGE$689
- Selectra$689
- PAMIRA$689
- ENSITE$522
- AVEIR$507
- ADVISA DR MRI SURESCAN$178
- NUVISION ICE CATHETER$117
- LifeVest$103
How this compares
$29,211 in reported general payments places this provider in the 90th percentile of 415 cardiovascular disease providers in Connecticut.
Other cardiovascular disease in Farmington
- John HinsonFarmington$19K
- Nihar DesaiNew Haven$1.4M
- Brett NowlanBloomfield$798K
- Jeffery TestaniNew Haven$546K
- Carlos Mena-HurtadoNew Haven$460K
- Stephanie SaucierHartford$243K
- John ForrestNew Haven$164K
- Henry WardNew Haven$152K
- Ricardo CordidoHamden$135K
- Antonio FernandezHartford$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.